The Relationship Between Lipid Peroxidation and LDL Desialylation in Experimental Atherosclerosis

REFERENCES

• Allon R., Bayer E. A., Wilchek M. A coupled enzyme assay for measurement of sialidase activity. J. Biochem. Biophys. Methods 1991; 22: 23–33
   PubMedGoogle Scholar
• Aviram M. The contribution of macrophage receptor for oxidized LDL to its cellular uptake. Biochem. Biophys. Res. Commun. 1991; 179: 359–365
   PubMed Web of Science ®Google Scholar
• Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993; 98: 1–9
   PubMed Web of Science ®Google Scholar
• Barbosa D. S., Maranhoa R. C., Arauja F. B., Chang Y. J., Hirata M. H., Abdalla D. S. P. Sialic acid and oxidazibility of low density lipoprotein subfractions of hyperlipidemic patients. Clin. Biochem. 1995; 28: 435–441
   PubMed Web of Science ®Google Scholar
• Brousseau T., Clavey V., Bard J. M., Fruchart J. C. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins and lipoprotein particles. Clin. Chem. 1993; 39: 960–964
   PubMed Web of Science ®Google Scholar
• Buege J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol. 1978; 52: 302–310
   PubMedGoogle Scholar
• Dousset N. Dousset J. C., Taus M. Ferretti G. Curatola G. Solera M. L., Valdique P. Effect of desialylation on low density lipoproteins: comparative study before and after oxidative stress. Biochem. Mol. Biol. Int. 1994; 32: 555–563
   PubMedGoogle Scholar
• Dousset N., Ferretti G., Taus M., Solera M., Dousset J. C., Valdique P. Physico-chemical modifications in desialylated low density lipoproteins. Nutr. Metab. Cardiovasc. Dis. 1998; 8: 366–370
   Web of Science ®Google Scholar
• Hessler J. R., Robertson A. L., Chilsom G. M. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979; 32: 213–229
   PubMed Web of Science ®Google Scholar
• Jurgens G., Hoff H. F., Chisolm G. M. Modification of human serum low density lipoprotein by oxidation-characterization and pathophysiological implications. Chem. Phys. Lipids 1987; 45: 315–336
   PubMed Web of Science ®Google Scholar
• Keidar S., Brook J. G., Rosenbalt M., Fhrman Danker G., Aviram M. Involvement of macrophage LDL receptor binding domains in the uptake of oxidized LDL. Arterioscl. Thromb. 1992; 4: 484–493
   Google Scholar
• Kimura N., Keys A. Coronary heart disease in seven countries. X. Rural southern Japan. Circulation 1970; 41: 101–112
   PubMed Web of Science ®Google Scholar
• Knott T. J., Pease P. J., Powell L. M., Wallis S. C., Rall S. C., Jr., Blackhart B., Taylor W. L. L., Marceal Y., Milne R. Complete protein sequence and identification of structural domains of human apolipoprotein B. Nature 1986; 323: 734–738
   PubMed Web of Science ®Google Scholar
• Kokoglu E., Suer S., Sonmez H., Ucisik N. The relationship between the electrophoretic mobility of lipoproteins and coronary heart disease. Res. Commun. Mol. Pathol. Pharmacol. 1996; 91: 109–116
   PubMedGoogle Scholar
• La Belle M., Krauss R. M. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclasses patterns. J. Lipid. Res. 1990; 31: 1577–1588
   PubMed Web of Science ®Google Scholar
• Lowry O. H., Rosenbrough N. J., Furn A. C., Randall R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951; 193: 265
   PubMed Web of Science ®Google Scholar
• Martin M. J., Hully S. B., Browner W. S., Kuller L. H., Wentworth D. Serum cholesterol, blood pressure and mortality: implications from a cohort of 361 662 men. Lancet 1986; 2: 933–936
   PubMed Web of Science ®Google Scholar
• Millar J. S., Anber V., Shepherd J., Packard C. J. Sialic acid-containing components of lipoproteins influence lipoprotein-proteoglycan interactions. Atherosclerosis 1999; 145: 253–260
   PubMed Web of Science ®Google Scholar
• Myara I., Haberland M. E., Demuth K., Chappey B., Moatti N. Susceptibility to copper oxidation of neuraminidase treated LDL. Clin. Chim. Acta. 1995; 240: 221–223
   PubMed Web of Science ®Google Scholar
• Orekhov A. N., Tertov V. V., Mukhin D. N., Mikhailenko I. A. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. Biochem. Biophys. Res. Commun. 1989; 162: 206–211
   PubMed Web of Science ®Google Scholar
• Orekhov A. N., Tertov. V. V., Mukhin D. N. Desialylated low density lipoprotein naturally occurring modified lipoprotein with atherogenic potency. Atherosclerosis 1991; 86: 153–161
   PubMed Web of Science ®Google Scholar
• Orekhov A. N., Tertov V. V., Pokrovsky S. N., Adamova I. Yu., Martsenyuk O. N., Lyakishev A. A., Smirnov V. N. Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination. Circ. Res. 1988; 62: 421–429
   PubMed Web of Science ®Google Scholar
• Orekhov A. N., Tertov V. V., Sobenin I. A., Smirnov V. N., Via D. P., Guevara J., Jr., Gotto A. M., Jr., Morrisett J. D. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. J. Lipid Res. 1992; 33: 805–817
   PubMed Web of Science ®Google Scholar
• Sattler W., Kostner G. M., Waeg G., Esterbauer H. Oxidation of lipoprotein Lp(a). A comparison with low density lipoproteins. Biochim. Biophys. Acta 1991; 1081: 65–74
   PubMed Web of Science ®Google Scholar
• Schwartz C. J., Valente A. J., Sprague E. A. A modern view of atherogenesis. Am. J. Cardiol. 1993; 71: 9B–14B
   PubMed Web of Science ®Google Scholar
• Sobenin I. A., Tertov V. V., Konchinsky T., Bünting C. E., Slavina E. S., Dedov I. I., Orekhov A. N. Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells. Atherosclerosis 1993; 100: 41–54
   PubMed Web of Science ®Google Scholar
• Sonmez H., Suer S., Ulutin T., Kokoğlu E., Üçişik N. The relationship of various factors in the pathogenesis of atherosclerosis. Clin. Appl. Thrombosis/Hemostasis 1998; 4: 105–110
   Web of Science ®Google Scholar
• Sparow C. P., Parhasarathy S., Steinberg D. Macrophage receptor that recognizes oxidized LDL not acetylated LDL. J. Biol. Chem. 1989; 264: 2599–2604
   PubMed Web of Science ®Google Scholar
• Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol: modification of low density lipoprotein that increase its atherogenecity. New Engl. J. Med. 1989; 320: 915–924
   PubMed Web of Science ®Google Scholar
• Steinbrecher U. P., Parthasarathy S., Leake D. S., Wiztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 1984; 81: 3883–3887
   PubMed Web of Science ®Google Scholar
• Swaminathan N., Aladjen F. The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. Biochemistry 1976; 15: 1516–1522
   PubMed Web of Science ®Google Scholar
• Tanaka K., Tokumaru S., Kojo S. Possible involvement of radical reactions in desialylation of LDL. FEBS Lett. 1997; 413: 202–204
   PubMed Web of Science ®Google Scholar
• Taniguchi T., Ishikawa Y., Tsunemitsu M., Fukuzaki I. I. The structures of the asparagine-linked sugar chains of human apolipoprotein B-100. Arch. Biochem. Biophys. 1989; 273: 197–205
   PubMed Web of Science ®Google Scholar
• Tertov V. V., Kaplun V. V., Sobenin I. A., Boytsova E. Y., Bovin N. V., Orekhov A. N. Human plasma trans-sialidase causes atherogenic modification of low density lipoprotein. Atherosclerosis 2001; 159(1)103–115
   PubMed Web of Science ®Google Scholar
• Tertov V. V., Kaplun V. V., Sobenin I. A., Orekhov A. N. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification. Atherosclerosis 1998; 138: 183–195
   PubMed Web of Science ®Google Scholar
• Tertov V. V., Orekhov A. N., Martsenyuk O. N., Perova N. V., Smirnov V. N. Low-density lipoproteins isolated from the blood of patients with coronary heart disease induce the accumulation of lipids in human aortic cells. Exp. Mol. Pathol. 1989; 50: 337–347
   PubMed Web of Science ®Google Scholar
• Tertov V. V., Orekhov A. N., Sobenin I. A., Morrisett J. D., Gotto A. M., Jr., Guevara J. G., Jr. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. J. Lipid Res. 1993; 34: 365–375
   PubMed Web of Science ®Google Scholar
• Tertov V. V., Sobenin I. A., Gabbasov Z. A., Popov E. G., Jaakkola O., Solakivi T., Nikkari T., Smirnov V. N., Orekhov A. N. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Lab Invest 1992; 67: 665–675
   PubMed Web of Science ®Google Scholar
• Tertov V. V., Sobenin I. A, Orekhov A. N., Jaakkola O., Solakivi T., Nikkari T. Characteristics of low density lipoprotein isolated from circulating immune complexes. Atherosclerosis 1996; 122: 191–199
   PubMed Web of Science ®Google Scholar
• Wang M. Atherosclerosis: the past, the present and the future. Atherosclerosis 2001; 3: 1–25
   Google Scholar
• Warren L. The thiobarbituric acid assay of sialic acids. J. Biol. Chem. 1959; 234: 1971–1975
   PubMed Web of Science ®Google Scholar
• Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 1991; 88: 1875–1892
   Web of Science ®Google Scholar